Αρχική World News Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II Colon... World News Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II Colon Cancer Από Ogkologos - 30 Ιουλίου, 2026 185 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CIRCULATE, an AIO (KRK-0217)/ABCSG study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ EMA recommends granting a marketing authorisation for daraxonrasib Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? MOST POPULAR Groundbreaking Trial Results Expand Treatment Options for Some People with Bladder... 30 Νοεμβρίου, 2023 For Some Women with Breast Cancer, Cost Influences Decisions about Surgery 6 Σεπτεμβρίου, 2019 Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer... 4 Νοεμβρίου, 2025 Wishes for a New Year! 31 Δεκεμβρίου, 2021 Φόρτωση περισσοτέρων HOT NEWS Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated... 27-Year-Old Thought She Was Injured Falling Off A Horse, But Then... Ability of Deep Learning to Accurately Diagnose Frequent STS Subtypes from... ESMO Welcomes the European Parliament’s (EP) Call for a Sustainable Cancer...